SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-002428
Filing Date
2019-02-08
Accepted
2019-02-08 16:06:35
Documents
58
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-10q_20181231.htm 10-Q 1730684
2 EX-31.1 enta-ex311_6.htm EX-31.1 16205
3 EX-31.2 enta-ex312_7.htm EX-31.2 16191
4 EX-32.1 enta-ex321_8.htm EX-32.1 8936
5 GRAPHIC ghbw4l3jb2vr000001.jpg GRAPHIC 72207
  Complete submission text file 0001564590-19-002428.txt   6280792

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enta-20181231.xml EX-101.INS 1492297
7 XBRL TAXONOMY EXTENSION SCHEMA enta-20181231.xsd EX-101.SCH 34843
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20181231_cal.xml EX-101.CAL 43608
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20181231_def.xml EX-101.DEF 115423
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20181231_lab.xml EX-101.LAB 288707
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20181231_pre.xml EX-101.PRE 238085
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 19579919
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1